3 result(s) for serum in Health & Wellness
Two More Vaccines Licensed In Hungary: CanSino & Covishield
- 23 Mar 2021 6:13 AM
- hungarymatters.hu
- health & wellness
Hungary's medicines authority OGYÉI has granted licences for use to the Chinese CanSino coronavirus vaccine and Covishield, AstraZeneca's vaccine produced in India, the chief medical officer said.
Hungarian Public Health Authority Researches 'UK Variant'
- 26 Jan 2021 7:51 AM
- hungarymatters.hu
- health & wellness
The Hungarian public health authority (NNK) is researching a fast-spreading variant of the coronavirus, first detected in the United Kingdom late last year, to determine whether currently available vaccines would be effective against it.
Hungary Seeks Donors From Recovered Covid-19 Patients For Serum
- 23 Apr 2020 8:20 AM
- hungarymatters.hu
- health & wellness
The ministry of innovation and technology is seeking blood plasma donors among people who have recovered from the novel coronavirus epidemic for a therapy, currently in an experimental phase, which aims to alleviate patients' symptoms.
Two More Vaccines Licensed In Hungary: CanSino & Covishield
- 23 Mar 2021 6:13 AM
- hungarymatters.hu
- health & wellness
Hungary's medicines authority OGYÉI has granted licences for use to the Chinese CanSino coronavirus vaccine and Covishield, AstraZeneca's vaccine produced in India, the chief medical officer said.
Hungarian Public Health Authority Researches 'UK Variant'
- 26 Jan 2021 7:51 AM
- hungarymatters.hu
- health & wellness
The Hungarian public health authority (NNK) is researching a fast-spreading variant of the coronavirus, first detected in the United Kingdom late last year, to determine whether currently available vaccines would be effective against it.
Hungary Seeks Donors From Recovered Covid-19 Patients For Serum
- 23 Apr 2020 8:20 AM
- hungarymatters.hu
- health & wellness
The ministry of innovation and technology is seeking blood plasma donors among people who have recovered from the novel coronavirus epidemic for a therapy, currently in an experimental phase, which aims to alleviate patients' symptoms.